Research on colon cancer has shown that the level of TIPE2 in colon cancer tissues is significantly upregulated compared to adjacent normal tissues and that TIPE2 participates in the development of colon cancer by binding caspase 8, thereby inhibiting the TLR4 inflammatory pathway 40. Here, CASP8 is linked to colonic neoplasm.